Pictet Asset Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.7M Sell
700,311
-181,124
-21% -$9.83M 0.04% 353
2025
Q4
$40.7M Sell
881,435
-148,194
-14% -$6.63M 0.04% 364
2025
Q3
$37.1M Sell
1,029,629
-146,032
-12% -$4.84M 0.04% 379
2025
Q2
$38.2M Buy
1,175,661
+124,983
+12% +$4.1M 0.04% 363
2025
Q1
$42.2M Buy
1,050,678
+32,833
+3% +$2.63M 0.05% 341
2024
Q4
$83.3M Buy
1,017,845
+236,940
+30% +$23.5M 0.09% 229
2024
Q3
$89.2M Buy
780,905
+248,001
+47% +$22.4M 0.1% 212
2024
Q2
$40.2M Sell
532,904
-328,665
-38% -$22.4M 0.05% 321
2024
Q1
$58.9M Sell
861,569
-287,640
-25% -$19.9M 0.06% 281
2023
Q4
$72.2M Sell
1,149,209
-325,573
-22% -$16.9M 0.08% 248
2023
Q3
$75.2M Buy
+1,474,782
New +$72.8M 0.09% 226

Other funds holding PCVX